Enass A Abdel-Hameed1, Hong Ji, Kenneth E Sherman, Mohamed T M Shata. 1. *Department of Internal Medicine, Division of Digestive Diseases, University of Cincinnati Medical Center, Cincinnati, OH; and †Division of Asthma Research, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Abstract
OBJECTIVES: HIV-1 modulates host cell epigenetic machinery to control its own replication and induce immune suppression. HIV-1 infection leads to activation of T regulatory cell (T(reg)), but the mechanism underlying this immune modulation is unclear. T(reg) plays a prominent role in gut-mucosal immune tolerance by restraining excessive effector T-cell responses, a mechanism that is known to be disturbed in chronic HIV-1 infection. DNA methylation plays a major role in T(reg) lineage commitment and immune homeostasis, which may be regulated by HIV. To investigate the mechanisms of aberrant methylation of the T(reg) marker FOXP3 in HIV-1 infection, we evaluated the expression pattern of methylation-related enzymes and its correlation to FOXP3 methylation. METHODS: FOXP3 promoter methylation in the colon mucosa and peripheral blood from HIV-infected patients and control subjects was measured using Pyrosequencing. Gene expression pattern of DNA methylation enzymes in the colon mucosa was investigated by Microarray and quantitative reverse transcriptase-polymerase chain reaction analysis in the same subjects. RESULTS: FOXP3 promoter was significantly (P ≤ 0.0001) demethylated in HIV-infected patients compared with control subjects in both tissues. Expression of DNA methyltransferase 1 (DNAMT1), DNA methyltransferase 1-associated protein 1(DMAP1), methyltransferase-like 7B (METTL7B), and methyltransferase-like 10 (METTL10) were significantly down regulated in HIV-infected patients compared with controls and had a significant positive correlation to FOXP3 promoter methylation. CONCLUSIONS: We present evidence suggesting that altered methylation pattern of FOXP3 and accordingly higher T(reg) frequency in gut mucosa of HIV-infected patients may be because of aberrant methylation processing in HIV.
OBJECTIVES:HIV-1 modulates host cell epigenetic machinery to control its own replication and induce immune suppression. HIV-1 infection leads to activation of T regulatory cell (T(reg)), but the mechanism underlying this immune modulation is unclear. T(reg) plays a prominent role in gut-mucosal immune tolerance by restraining excessive effector T-cell responses, a mechanism that is known to be disturbed in chronic HIV-1 infection. DNA methylation plays a major role in T(reg) lineage commitment and immune homeostasis, which may be regulated by HIV. To investigate the mechanisms of aberrant methylation of the T(reg) marker FOXP3 in HIV-1 infection, we evaluated the expression pattern of methylation-related enzymes and its correlation to FOXP3 methylation. METHODS:FOXP3 promoter methylation in the colon mucosa and peripheral blood from HIV-infectedpatients and control subjects was measured using Pyrosequencing. Gene expression pattern of DNA methylation enzymes in the colon mucosa was investigated by Microarray and quantitative reverse transcriptase-polymerase chain reaction analysis in the same subjects. RESULTS:FOXP3 promoter was significantly (P ≤ 0.0001) demethylated in HIV-infectedpatients compared with control subjects in both tissues. Expression of DNA methyltransferase 1 (DNAMT1), DNA methyltransferase 1-associated protein 1(DMAP1), methyltransferase-like 7B (METTL7B), and methyltransferase-like 10 (METTL10) were significantly down regulated in HIV-infectedpatients compared with controls and had a significant positive correlation to FOXP3 promoter methylation. CONCLUSIONS: We present evidence suggesting that altered methylation pattern of FOXP3 and accordingly higher T(reg) frequency in gut mucosa of HIV-infectedpatients may be because of aberrant methylation processing in HIV.
Authors: Jana Blazkova; Danielle Murray; J Shawn Justement; Emily K Funk; Amy K Nelson; Susan Moir; Tae-Wook Chun; Anthony S Fauci Journal: J Virol Date: 2012-02-15 Impact factor: 5.103
Authors: Yoav Keynan; Catherine M Card; Paul J McLaren; Magdy R Dawood; Ken Kasper; Keith R Fowke Journal: Clin Infect Dis Date: 2008-04-01 Impact factor: 9.079
Authors: Peter C J Janson; Malin E Winerdal; Per Marits; Magnus Thörn; Rolf Ohlsson; Ola Winqvist Journal: PLoS One Date: 2008-02-20 Impact factor: 3.240
Authors: Michelle M Miller; Nnenna Akaronu; Elizabeth M Thompson; Sylvia F Hood; Jonathan E Fogle Journal: J Immunol Date: 2014-12-29 Impact factor: 5.422
Authors: Juliana T Maricato; Maria N Furtado; Maisa C Takenaka; Edsel R M Nunes; Patricia Fincatti; Fabiana M Meliso; Ismael D C G da Silva; Miriam G Jasiulionis; Maria Cecília de Araripe Sucupira; Ricardo Sobhie Diaz; Luiz M R Janini Journal: PLoS One Date: 2015-04-13 Impact factor: 3.240